Is Beximco Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Beximco Pharmaceuticals pays dividends. Last time was Thursday 8th of February 2024 where the investors holding the stock on Friday 10th of November 2023 were paid GBP2.340633 per share. Over the last 12 times between 2008 and 2023, Beximco Pharmaceuticals has paid GBP17.422519 with an average of GBP1.45 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Beximco Pharmaceuticals 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was GBP31.91, you would have made a loss of GBP-4.41 per share or -13.82%
Yes, the average daily trading liquidity for Beximco Pharmaceuticals is GBP171 591 thousand. You should therefore be able to get in and out of your positions relatively fast.
Beximco Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.13, the company's ability to pay off the debt is good. Beximco Pharmaceuticals has a good net profit margin of 12.37% and should have high tolerances against inflation.
We have calculated the inflation risk for Beximco Pharmaceuticals to be low [0.25 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.